Biomedicine & Biotech

When it comes to clinical trials of a norovirus vaccine – something that has been ongoing since the 1970s, it's the Wild West. The early vaccines were crude and the outcomes has been universally dismal.
From the frenzy of people who object to the use of mRNA technology in vaccines, one might conclude that genetic material from space aliens was being injected into people in some grand plan to convert humans into giant tadpoles.
Well, are you? I'm not kidding. This is real, not satire. 
Their eyes tell their sad stories as ghostly white irises give way to vacant stares. We can look at them, but they can’t look back at us.
When I first wrote Antibiotics – The Perfect Storm (2009-10), I described the various factors that went contributed to the conundrum that still confronts us today.
Lars began by emphasizing the urgency of advancing biotechnology safely. I reassured him that this is possible, highlighting two key factors: aggressive private sector investment, federally funded basic research, and science-based regulation.